QuidelOrtho PE Ratio 2010-2024 | QDEL
Current and historical p/e ratio for QuidelOrtho (QDEL) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. QuidelOrtho PE ratio as of March 26, 2025 is 23.71.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| QuidelOrtho PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-03-27 | 35.87 | 0.00 | |
| 2024-12-31 | 44.55 | $-30.28 | 0.00 |
| 2024-09-30 | 45.60 | $-27.90 | 0.00 |
| 2024-06-30 | 33.22 | $-27.79 | 0.00 |
| 2024-03-31 | 47.94 | $-26.39 | 0.00 |
| 2023-12-31 | 73.70 | $-0.16 | 0.00 |
| 2023-09-30 | 73.04 | $0.19 | 384.42 |
| 2023-06-30 | 82.86 | $0.66 | 125.55 |
| 2023-03-31 | 89.09 | $1.82 | 48.95 |
| 2022-12-31 | 85.67 | $12.40 | 6.91 |
| 2022-09-30 | 71.48 | $18.80 | 3.80 |
| 2022-06-30 | 97.18 | $23.60 | 4.12 |
| 2022-03-31 | 112.46 | $23.69 | 4.75 |
| 2021-12-31 | 134.99 | $16.47 | 8.20 |
| 2021-09-30 | 141.15 | $20.40 | 6.92 |
| 2021-06-30 | 128.12 | $20.65 | 6.20 |
| 2021-03-31 | 127.93 | $21.75 | 5.88 |
| 2020-12-31 | 179.65 | $18.59 | 9.66 |
| 2020-09-30 | 219.38 | $8.52 | 25.75 |
| 2020-06-30 | 223.74 | $3.57 | 62.67 |
| 2020-03-31 | 97.81 | $2.05 | 47.71 |
| 2019-12-31 | 75.03 | $1.72 | 43.62 |
| 2019-09-30 | 61.35 | $1.79 | 34.27 |
| 2019-06-30 | 59.32 | $1.68 | 35.31 |
| 2019-03-31 | 65.47 | $1.57 | 41.70 |
| 2018-12-31 | 48.82 | $1.83 | 26.68 |
| 2018-09-30 | 65.17 | $0.90 | 72.41 |
| 2018-06-30 | 66.50 | $0.47 | 141.49 |
| 2018-03-31 | 51.81 | $0.20 | 259.05 |
| 2017-12-31 | 43.35 | $-0.24 | 0.00 |
| 2017-09-30 | 43.86 | $-0.15 | 0.00 |
| 2017-06-30 | 27.14 | $-0.01 | 0.00 |
| 2017-03-31 | 22.64 | $0.10 | 226.40 |
| 2016-12-31 | 21.42 | $-0.43 | 0.00 |
| 2016-09-30 | 22.09 | $-0.38 | 0.00 |
| 2016-06-30 | 17.86 | $-0.38 | 0.00 |
| 2016-03-31 | 17.26 | $-0.40 | 0.00 |
| 2015-12-31 | 21.20 | $-0.18 | 0.00 |
| 2015-09-30 | 18.88 | $0.03 | 629.33 |
| 2015-06-30 | 22.95 | $-0.12 | 0.00 |
| 2015-03-31 | 26.98 | $-0.06 | 0.00 |
| 2014-12-31 | 28.92 | $-0.21 | 0.00 |
| 2014-09-30 | 26.87 | $-0.38 | 0.00 |
| 2014-06-30 | 22.11 | $-0.34 | 0.00 |
| 2014-03-31 | 27.30 | $-0.19 | 0.00 |
| 2013-12-31 | 30.89 | $0.21 | 147.10 |
| 2013-09-30 | 28.40 | $0.44 | 64.55 |
| 2013-06-30 | 25.53 | $0.55 | 46.42 |
| 2013-03-31 | 23.75 | $0.50 | 47.50 |
| 2012-12-31 | 18.67 | $0.14 | 133.36 |
| 2012-09-30 | 18.93 | $-0.09 | 0.00 |
| 2012-06-30 | 15.68 | $-0.10 | 0.00 |
| 2012-03-31 | 18.37 | $-0.11 | 0.00 |
| 2011-12-31 | 15.13 | $0.24 | 63.04 |
| 2011-09-30 | 16.37 | $0.20 | 81.85 |
| 2011-06-30 | 15.15 | $0.02 | 757.50 |
| 2011-03-31 | 11.96 | $0.04 | 299.00 |
| 2010-12-31 | 14.45 | $-0.40 | 0.00 |
| 2010-09-30 | 10.99 | $0.28 | 39.25 |
| 2010-06-30 | 12.69 | $0.99 | 12.82 |
| 2010-03-31 | 14.54 | $1.10 | 13.22 |
| 2009-12-31 | 13.78 | $1.10 | 12.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.822B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |